(Q43629800)

25 November 2017

title

Treatment of chronic hepatitis delta with pegylated interferon-alpha2b (English)

1 reference

25 November 2017

1 reference

7

Tobias Heintges

1 reference

25 November 2017

8

Dieter Häussinger

1 reference

25 November 2017

Andreas Erhardt

1

1 reference

25 November 2017

Wolfram Gerlich

2

1 reference

25 November 2017

Christine Starke

3

1 reference

25 November 2017

Ulrike Wend

4

1 reference

25 November 2017

Andreas Donner

5

1 reference

25 November 2017

Abdurrahman Sagir

6

1 reference

25 November 2017

language of work or name

1 reference

1 September 2006

1 reference

25 November 2017

1 reference

25 November 2017

volume

26

1 reference

25 November 2017

issue

7

1 reference

25 November 2017

page(s)

805-810

1 reference

Delta hepatitis: an update

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2006.01279.X

Influence of hepatitis delta virus infection on morbidity and mortality in compensated cirrhosis type B. The European Concerted Action on Viral Hepatitis (Eurohep)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2006.01279.X

Treatment of hepatitis D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2006.01279.X

Treatment of chronic hepatitis D virus infection with low and high doses of interferon-alpha 2a: utility of polymerase chain reaction in monitoring antiviral response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2006.01279.X

Treatment of chronic hepatitis D with interferon alpha-2b in patients with human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2006.01279.X

Long-term benefit of interferon alpha therapy of chronic hepatitis D: regression of advanced hepatic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2006.01279.X

Ribavirin therapy in chronic delta hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2006.01279.X

Lamivudine-high dose interferon combination therapy for chronic hepatitis B patients co-infected with the hepatitis D virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2006.01279.X

A prenylation inhibitor prevents production of infectious hepatitis delta virus particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2006.01279.X

Influence of hepatitis delta virus infection on progression to cirrhosis in chronic hepatitis type B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2006.01279.X

Rapidly progressive HBsAg-positive hepatitis in Italy. The role of hepatitis delta virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2006.01279.X

Role of hepatitis delta virus infection in hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2006.01279.X

Peginterferon alpha-2a (40 kDa): an advance in the treatment of hepatitis B e antigen-positive chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2006.01279.X

A randomized, double-blind trial comparing pegylated interferon alfa-2b to interferon alfa-2b as initial treatment for chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2006.01279.X

Response to interferon alfa is hepatitis B virus genotype dependent: genotype A is more sensitive to interferon than genotype D

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2006.01279.X

Histological grading and staging of chronic hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2006.01279.X

Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2006.01279.X

10.1111/J.1478-3231.2006.01279.X

21 January 2018

Identifiers

DOI

1 reference

25 November 2017

1 reference